Disruption of neuronal-glial-vascular units in the hippocampus of ovariectomized mice injected with d-galactose

Neuroscience

Volumn 169, Issue 2, 2010, Pages 596-608

  Liu, L ^a   Su, Y ^a   Yang, W ^a   Xiao, M ^a   Gao, J ^a   Hu, G ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Astrocytes; D galactose; Glutamate uptake; Neurodegeneration; Water transport

Indexed keywords

AMINO ACID TRANSPORTER; AQUAPORIN 4; ASPARTATE TRANSPORTER; CONNEXIN 43; GALACTOSE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MOUSE; NERVE DEGENERATION; NEURONAL GLIAL VASCULAR UNITS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIUM;

ALZHEIMER DISEASE; ANIMALS; AQUAPORIN 4; BIOLOGICAL TRANSPORT; CELL COMMUNICATION; CONNEXIN 43; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GALACTOSE; GIANT CELLS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; HIPPOCAMPUS; MICE; MICROVESSELS; NEUROGLIA; NEURONS; OVARIECTOMY; WATER;

EID: 77954622958     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.05.028     Document Type: Article

References (65)

1. Alexander G.E., Chen K., Pietrini P., Rapoport S.I., Reiman E.M. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry 2002, 159:738-745.
2. Allaman I., Gavillet M., Bélanger M., Laroche T., Viertl D., Lashuel H.A., Magistretti P.J. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 2010, 30:3326-3338.
3. Allen N.J., Barres B.A. Neuroscience: glia-more than just brain glue. Nature 2009, 457:675-677.
4. Amiry-Moghaddam M., Ottersen O.P. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003, 4:991-1001.
5. Blutstein T., Devidze N., Choleris E., Jasnow A.M., Pfaff D.W., Mong J.A. Oestradiol up-regulates glutamine synthetase mRNA and protein expression in the hypothalamus and hippocampus: implications for a role of hormonally responsive glia in amino acid neurotransmission. J Neuroendocrinol 2006, 18:692-702.
6. Bushong E.A., Martone M.E., Jones Y.Z., Ellisman M.H. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 2002, 22:183-192.
7. Butterfield D.A., Hensley K., Cole P., Subramaniam R., Aksenov M., Aksenova M., Bummer P.M., Haley B.E., Carney J.M. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J Neurochem 1997, 68:2451-2457.
8. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 2002, 33:562-571.
9. Chan P.H., Chu L., Chen S. Effects of MK-801 on glutamate-induced swelling of astrocytes in primary cell culture. J Neurosci Res 1990, 25:87-93.
10. Cui X., Zuo P., Zhang Q., Li X., Hu Y., Long J., Packer L., Liu J. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res 2006, 84:647-654.
11. Dabir D.V., Robinson M.B., Swanson E., Zhang B., Trojanowski J.Q., Lee V.M., Forman M.S. Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J Neurosci 2006, 26:644-654.
12. Desai B.S., Monahan A.J., Carvey P.M., Hendey B. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant 2007, 16:285-299.
13. Dhandapani K.M., Brann D.W. Role of astrocytes in estrogen-mediated neuroprotection. Exp Gerontol 2007, 42:70-75.
14. Dringen R., Hirrlinger J. Glutathione pathways in the brain. Biol Chem 2003, 384:505-516.
15. Fatemi S.H., Folsom T.D., Reutiman T.J., Lee S. Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse 2008, 62:501-507.
16. Fuller S., Münch G., Steele M. Activated astrocytes: a therapeutic target in Alzheimer's disease?. Expert Rev Neurother 2009, 9:1585-1594.
17. Gong Y., Liu L., Xie B., Liao Y., Yang E., Sun Z. Ameliorative effects of lotus seedpod proanthocyanidins on cognitive deficits and oxidative damage in senescence-accelerated mice. Behav Brain Res 2008, 194:100-107.
18. Gunnarson E., Zelenina M., Axehult G., Song Y., Bondar A., Krieger P., Brismar H., Zelenin S., Aperia A. Identification of a molecular target for glutamate regulation of astrocyte water permeability. Glia 2008, 56:587-596.
19. Guo S., Lo E.H. Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke 2009, 40:S4-S7.
20. Han B.C., Koh S.B., Lee E.Y., Seong Y.H. Regional difference of glutamate-induced swelling in cultured rat brain astrocytes. Life Sci 2004, 76:573-583.
21. Hirase H. A multi-photon window onto neuronal-glial-vascular communication. Trends Neurosci 2005, 28:217-219.
22. Ho S.C., Liu J.H., Wu R.Y. Establishment of the mimetic aging effect in mice caused by D-galactose. Biogerontology 2003, 4:15-18.
23. Hsieh H.M., Wu W.M., Hu M.L. Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer's disease in C57BL/6J mice treated with d-galactose. Food Chem Toxicol 2009, 47:625-632.
24. Hua X., Lei M., Ding J., Han Q., Hu G., Xiao M. Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with d-galactose: a potential contribution to Alzheimer's disease processes. Exp Neurol 2008, 210:709-718.
25. Hua X., Lei M., Zhang Y., Ding J., Han Q., Hu G., Xiao M. Long-term d-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease. Life Sci 2007, 80:1897-1905.
26. Jarius S., Paul F., Franciotta D., Waters P., Zipp F., Hohlfeld R., Vincent A., Wildemann B. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008, 4:202-214.
27. Koyama Y., Sugimoto T., Shigenaga Y., Baba A., Iwata H. A morphological study on glutamate-induced swelling of cultured astrocytes: involvement of calcium and chloride ion mechanisms. Neurosci Lett 1991, 124:235-238.
28. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesbery W.R., Butterfield D.A. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 2001, 78:413-416.
29. Lehre K.P., Levy L., Ottersen O.P., Storm-Mathisen J., Danbolt N.C. Differential expression of two glial glutamate transportersin the rat brain: quantitative and immunocytochemical observations. J Neurosci 1995, 15:1835-1853.
30. Lei M., Su Y., Hua X., Ding J., Han Q., Hu G., Xiao M. Chronic systemic injection of d-galactose impairs the septohippocampal cholinergic system in rats. Neuroreport 2008, 19:1611-1615.
31. Li S., Mallory M., Alford M., Tanaka S., Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 1997, 56:901-911.
32. Li X., Kong H., Wu W., Xiao M., Sun X., Hu G. Aquaporin-4 maintains ependymal integrity in adult mice. Neuroscience 2009, 162:67-77.
33. Liu H., Wang H., Shenvi S., Hagen T.M., Liu R.M. Glutathione metabolism during aging and in Alzheimer disease. Ann N Y Acad Sci 2004, 1019:346-349.
34. Luo Y., Niu F., Sun Z., Cao W., Zhang X., Guan D., Lv Z., Zhang B., Xu Y. Altered expression of Abeta metabolism-associated molecules from d-galactose/AlCl(3) induced mouse brain. Mech Ageing Dev 2009, 130:248-252.
35. Maragakis N.J., Rothstein J.D. Glutamate transporters in neurologic disease. Arch Neurol 2001, 58:365-370.
36. Maragakis N.J., Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006, 2:679-689.
37. Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 1996, 40:759-766.
38. Matsuoka T., Matsushita T., Kawano Y., Osoegawa M., Ochi H., Ishizu T., Minohara M., Kikuchi H., Mihara F., Ohyagi Y., Kira J. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007, 130:1206-1223.
39. Nagy J.I., Li W., Hertzberg E.L., Marotta C.A. Elevated connexin 43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res 1996, 717:173-178.
40. Newman E.A. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 2003, 26:536-542.
41. Ogata K., Kosaka T. Structural and quantitative analysis of astrocytes in the mouse hippocampus. Neuroscience 2002, 113:221-233.
42. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, 45-50. Academic Press, San Diego, CA. 2nd ed.
43. Pérez E., Barrachina M., Rodríguez A., Torrejón-Escribano B., Boada M., Hernández I., Sánchez M., Ferrer I. Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimer disease. Brain Res 2007, 1128:164-174.
44. Pines G., Danbolt N.C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B.I. Cloning and expression of a rat brain L-glutamate transporter. Nature 1992, 360:464-467.
45. Robinson S.R. Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease. J Neurosci Res 2001, 66:972-980.
46. Rodríguez J.J., Olabarria M., Chvatal A., Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ 2009, 16:378-385.
47. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
48. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 2006, 7:194-206.
49. Storck T., Schulte S., Hofmann K., Stoffel W. Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci U S A 1992, 89:10955-10959.
50. Struzyńska L., Chalimoniuk M., Sulkowski G. Changes in expression of neuronal and glial glutamate transporters in lead-exposed adult rat brain. Neurochem Int 2005, 47:326-333.
51. Su Y., Sun H., Fang J., Hu G., Xiao M. Brain mitochondrial dysfunction in ovariectomized mice injected with d-galactose. Neurochem Res 2010, 35:399-404.
52. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
53. Ventura R., Harris K.M. Three-dimensional relationships between hippocampal synapses and astrocytes. J Neurosci 1999, 19:6897-6906.
54. Verkhratsky A., Kirchhoff F. Glutamate-mediated neuronal-glial transmission. J Anat 2007, 210:651-660.
55. Verkman A.S. More than just water channels: unexpected cellular roles of aquaporins. J Cell Sci 2005, 118:3225-3232.
56. Voutsinos-Porche B., Bonvento G., Tanaka K., Steiner P., Welker E., Chatton J.Y., Magistretti P.J., Pellerin L. Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex. Neuron 2003, 37:187-189.
57. Walton H.S., Dodd P.R. Glutamate-glutamine cycling in Alzheimer's disease. Neurochem Int 2007, 50:1052-1066.
58. Wei H., Li L., Song Q., Ai H., Chu J., Li W. Behavioural study of the d-galactose induced aging model in C57BL/6J mice. Behav Brain Res 2005, 157:245-251.
59. Wilcock D.M., Vitek M.P., Colton C.A. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neuroscience 2009, 159:1055-1069.
60. Wilhelmsson U., Bushong E.A., Price D.L., Smarr B.L., Phung V., Terada M., Ellisman M.H., Pekny M. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A 2006, 103:17513-17518.
61. Wu D.M., Lu J., Zheng Y.L., Zhou Z., Shan Q., Ma D.F. Purple sweet potato color repairs d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. Neurobiol Learn Mem 2008, 90:19-27.
62. Yao X., Hrabetová S., Nicholson C., Manley G.T. Aquaporin-4 deficient mice have increased extracellular space without tortuosity change. J Neurosci 2008, 28:5460-5464.
63. Zeng X.N., Sun X.L., Gao L., Fan Y., Ding J.H., Hu G. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol Cell Neurosci 2007, 34:34-39.
64. Zhang X.L., Jiang B., Li Z.B., Hao S., An L.J. Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Pharmacol Biochem Behav 2007, 88:64-72.
65. Zhou J., Kong H., Hua X., Xiao M., Ding J., Hu G. Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice. Neuroreport 2008, 19:1-5.